NEVVI Medicare utilization intelligence

← back

Provider profile

DOMMASCH, ERICA MD

Dermatology · NPI 1003136771 · BOSTON, MA

3
Groups
17
Codes · 2024
1,284
Disclosed services

DOMMASCH, ERICA is a Dermatology in BOSTON, MA, a member of 3 medical groups, who billed 17 distinct codes to Medicare Part B in 2024.

Groups: ATRIUS HEALTH INC (BOSTON, MA) · RELIANT MEDICAL GROUP INC (WORCESTER, MA) · SPRING STREET DERMATOLOGY, PLLC (NEW YORK, NY) — member of 3 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

1,284
disclosed services
17
codes billed to Medicare Part B
Prior year · CY2023 1,810 disclosed services

This provider's disclosed Medicare payments across all codes were premium in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
17003 Destruction of precancer skin growth, 2-14 growths premiumpremium premiumpremium
17000 Destruction of precancer skin growth, 1 growth premiumpremium premiumpremium
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more premiumpremium premiumpremium
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more premiumpremium premiumpremium
11102 Biopsy of related skin growth, first growth premiumpremium premiumpremium
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more premiumpremium premiumpremium
17110 Destruction of skin growth, 1-14 growths premiumpremium premiumpremium
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more premiumpremium premiumpremium
11103 Biopsy of related skin growth, each additional growth premiumpremium premiumpremium
36415 Insertion of needle into vein for collection of blood sample premiumpremium premiumpremium
82746 Folic acid level, serum premiumpremium premiumpremium
11104 Punch biopsy, first skin growth premiumpremium premiumpremium
82607 Cyanocobalamin (vitamin b-12) level premiumpremium premiumpremium
82728 Ferritin (blood protein) level premiumpremium premiumpremium
83540 Iron level premiumpremium premiumpremium
84466 Transferrin (iron binding protein) level premiumpremium premiumpremium
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.